These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Advantages of hypothermic potassium cardioplegia and superiority of continuous versus intermittent aortic cross-clamping. Roberts AJ; Abel RM; Alonso DR; Subramanian VA; Paul JS; Gay WA J Thorac Cardiovasc Surg; 1980 Jan; 79(1):44-58. PubMed ID: 7350388 [TBL] [Abstract][Full Text] [Related]
7. Myocardial protection during prolonged aortic cross-clamping. Comparison of blood and crystalloid cardioplegia. Catinella FP; Cunningham JN; Spencer FC J Thorac Cardiovasc Surg; 1984 Sep; 88(3):411-23. PubMed ID: 6471891 [TBL] [Abstract][Full Text] [Related]
8. Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood, and Fluosol-DA cardioplegia during prolonged aortic clamping. Novick RJ; Stefaniszyn HJ; Michel RP; Burdon FD; Salerno TA J Thorac Cardiovasc Surg; 1985 Apr; 89(4):547-66. PubMed ID: 3157028 [TBL] [Abstract][Full Text] [Related]
9. Effect of the pH of cardioplegic solution on postarrest myocardial preservation. Nugent WC; Levine FH; Liapis CD; LaRaia PJ; Tsai CH; Buckley MJ Circulation; 1982 Aug; 66(2 Pt 2):I68-72. PubMed ID: 7083549 [TBL] [Abstract][Full Text] [Related]
10. Normokalemic adenosine-lidocaine cardioplegia: importance of maintaining a polarized myocardium for optimal arrest and reanimation. Sloots KL; Dobson GP J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1576-86. PubMed ID: 20132951 [TBL] [Abstract][Full Text] [Related]
11. Myocardial protection with pinacidil induced hyperpolarized arrest during cardiopulmonary bypass. Yu T; Yu Z; Liu X; Yang S; Ye Y Chin Med J (Engl); 2001 Dec; 114(12):1245-8. PubMed ID: 11793844 [TBL] [Abstract][Full Text] [Related]
12. [Functional and metabolic effects of nicardipine on ischemic rat hearts with multidose potassium cardioplegia]. Tachibana H Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):630-40. PubMed ID: 2373897 [TBL] [Abstract][Full Text] [Related]
13. The metabolic consequences of blood and crystalloid cardioplegia. Engelman RM; Rousou JH; Lemeshow S; Dobbs WA Circulation; 1981 Aug; 64(2 Pt 2):II67-74. PubMed ID: 6972829 [TBL] [Abstract][Full Text] [Related]
15. Superior action of magnesium-lidocaine-1-aspartate cardioplegia to glucose-insulin-potassium cardioplegia in experimental myocardial protection. Sunamori M; Amano J; Okamura T; Suzuki A Jpn J Surg; 1982; 12(5):372-80. PubMed ID: 6755010 [TBL] [Abstract][Full Text] [Related]
16. A clinical comparison of potassium and magnesium-potassium crystalloid cardioplegia: metabolic considerations. Engelman RM; Rousou JH; Lemeshow S; Dobbs WA J Cardiovasc Surg (Torino); 1985; 26(4):343-50. PubMed ID: 3874871 [TBL] [Abstract][Full Text] [Related]
17. Effects of coenzyme Q10 added to a potassium cardioplegic solution for myocardial protection during ischemic cardiac arrest. Mori F; Mohri H Ann Thorac Surg; 1985 Jan; 39(1):30-6. PubMed ID: 3966834 [TBL] [Abstract][Full Text] [Related]
19. Myocardial respiration and edema following hypothermic cardioplegia and anoxic arrest. Sunamori M; Harrison CE J Thorac Cardiovasc Surg; 1979 Aug; 78(2):208-16. PubMed ID: 459528 [TBL] [Abstract][Full Text] [Related]
20. The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation. Rousou JA; Engelman RM; Breyer RH; Otani H; Lemeshow S; Das DK J Thorac Cardiovasc Surg; 1988 Apr; 95(4):625-30. PubMed ID: 3352296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]